Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 41.0
(-5.86%)
TWD 41.0
(-5.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 254.35 Million TWD | -86.92% |
| 2022 | 1.94 Billion TWD | 957.4% |
| 2021 | 183.86 Million TWD | -1.07% |
| 2020 | 185.85 Million TWD | -72.77% |
| 2019 | 682.45 Million TWD | 57.41% |
| 2018 | 433.55 Million TWD | -14.27% |
| 2017 | 505.71 Million TWD | 62.57% |
| 2016 | 311.08 Million TWD | 26.85% |
| 2015 | 245.23 Million TWD | 189.87% |
| 2014 | 84.6 Million TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 250.52 Million TWD | 0.0% |
| 2024 Q1 | 251.3 Million TWD | 0.0% |
| 2023 Q1 | 1.94 Billion TWD | 0.23% |
| 2023 Q3 | 257.35 Million TWD | -1.15% |
| 2023 Q2 | 260.35 Million TWD | -86.64% |
| 2023 Q4 | 254.35 Million TWD | -1.17% |
| 2023 FY | 254.35 Million TWD | -86.92% |
| 2022 Q4 | 1.94 Billion TWD | 0.24% |
| 2022 Q3 | 1.93 Billion TWD | 0.24% |
| 2022 Q2 | 1.93 Billion TWD | 604.02% |
| 2022 FY | 1.94 Billion TWD | 957.4% |
| 2022 Q1 | 274.85 Million TWD | 49.49% |
| 2021 Q2 | 184.86 Million TWD | -0.27% |
| 2021 FY | 183.86 Million TWD | -1.07% |
| 2021 Q4 | 183.86 Million TWD | -0.27% |
| 2021 Q1 | 185.35 Million TWD | -0.27% |
| 2021 Q3 | 184.36 Million TWD | -0.27% |
| 2020 Q4 | 185.85 Million TWD | -70.67% |
| 2020 FY | 185.85 Million TWD | -72.77% |
| 2020 Q1 | 660.25 Million TWD | -3.25% |
| 2020 Q2 | 647.61 Million TWD | -1.92% |
| 2020 Q3 | 633.67 Million TWD | -2.15% |
| 2019 FY | 682.45 Million TWD | 57.41% |
| 2019 Q2 | 725.36 Million TWD | -2.85% |
| 2019 Q3 | 703.95 Million TWD | -2.95% |
| 2019 Q4 | 682.45 Million TWD | -3.05% |
| 2019 Q1 | 746.64 Million TWD | 72.22% |
| 2018 Q4 | 433.55 Million TWD | -4.2% |
| 2018 FY | 433.55 Million TWD | -14.27% |
| 2018 Q3 | 452.53 Million TWD | -4.29% |
| 2018 Q2 | 472.81 Million TWD | -3.2% |
| 2018 Q1 | 488.42 Million TWD | -3.42% |
| 2017 Q3 | 419.06 Million TWD | -3.59% |
| 2017 Q2 | 434.64 Million TWD | 0.0% |
| 2017 Q1 | - TWD | -100.0% |
| 2017 FY | 505.71 Million TWD | 62.57% |
| 2017 Q4 | 505.71 Million TWD | 20.68% |
| 2016 Q1 | 314.17 Million TWD | 28.11% |
| 2016 Q2 | 314.17 Million TWD | 0.0% |
| 2016 Q4 | 311.08 Million TWD | 0.0% |
| 2016 FY | 311.08 Million TWD | 26.85% |
| 2015 Q3 | 245.23 Million TWD | 57.76% |
| 2015 Q1 | 155.44 Million TWD | 83.74% |
| 2015 Q2 | 155.44 Million TWD | 0.0% |
| 2015 FY | 245.23 Million TWD | 189.87% |
| 2015 Q4 | 245.23 Million TWD | 0.0% |
| 2014 FY | 84.6 Million TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | 84.6 Million TWD | 0.0% |
| 2014 Q4 | 84.6 Million TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | -319.37% |
| Level Biotechnology Inc. | 9.88 Million TWD | -2473.151% |
| Sagittarius Life Science Corp | 6.25 Million TWD | -3967.093% |
| NeoCore Technology Co., Ltd. | 33.65 Million TWD | -655.842% |
| TaiMed Biologics Inc. | 521.7 Million TWD | 51.245% |
| GlycoNex Incorporation | - TWD | -Infinity% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 97.74 Million TWD | -160.232% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | -192.733% |
| Visgeneer Inc. | 114.17 Million TWD | -122.781% |
| Mycenax Biotech Inc. | 569.78 Million TWD | 55.359% |
| Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | -75.691% |
| G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -19556.569% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -53788.983% |
| Enimmune corporation | 1.75 Million TWD | -14360.262% |
| TaiRx, Inc. | 8.96 Million TWD | -2735.946% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 436.54 Million TWD | 41.734% |
| BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -394.539% |
| Sunny Pharmtech Inc. | 376.29 Million TWD | 32.405% |
| Lin BioScience, Inc. | 29.02 Million TWD | -776.304% |
| BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -2594.164% |
| Feng Chi Biotech Corp. | 8.14 Million TWD | -3021.315% |
| Bio Preventive Medicine Corp. | 106.2 Million TWD | -139.507% |
| Lukas Biomedical Inc. | 69.9 Million TWD | -263.86% |
| RBC Bioscience Corporation | 412.59 Million TWD | 38.353% |
| BiOptic Inc. | 85.79 Million TWD | -196.48% |
| BRIM Biotechnology, Inc. | 108 Thousand TWD | -235414.815% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -2237.616% |
| Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 34.117% |
| Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
| SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
| Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | -14.449% |
| Neith Corporation | 714 Thousand TWD | -35524.09% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 25.83 Million TWD | -884.464% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 30.505% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -1054.904% |
| Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -354.881% |
| Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -3033.621% |
| AP Biosciences Inc | 70.42 Million TWD | -261.163% |
| Medigen Biotechnology Corp. | 449.09 Million TWD | 43.363% |
| 3D Global Biotech Inc. | 4.08 Million TWD | -6131.161% |
| Pharmosa Biopharm Inc. | 118.41 Million TWD | -114.8% |
| Intech Biopharm Corporation | 970.4 Million TWD | 73.789% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 36.083% |
| Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -15737.858% |
| TWi Biotechnology, Inc. | 5.6 Million TWD | -4439.639% |
| Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -50467.793% |
| TCI GENE Inc. | - TWD | -Infinity% |
| MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -4419.474% |
| Senhwa Biosciences, Inc. | 3.28 Million TWD | -7638.242% |
| Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | -1.534% |
| NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -7690.383% |
| PharmaEngine, Inc. | 7.14 Million TWD | -3460.913% |
| Savior Lifetec Corporation | 257.03 Million TWD | 1.044% |
| TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | -333.241% |
| OBI Pharma, Inc. | 439.88 Million TWD | 42.177% |
| Meribank Biotech Co., Ltd | 14.81 Million TWD | -1617.345% |
| Acepodia, Inc. | 233.45 Million TWD | -8.955% |
| Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -2042.126% |